In addition, the atypical perinuclear antineutrophil cytoplasmic antibody (ANCA) serological marker is associated with the TNFRSF1B variant, and with IBD-related complications and non-response to anti-TNF [49]. Here, TNFRSF1B is linked to inflammatory bowel disease.